Recent research suggests new therapeutic role for caffeine in neuropsychiatric disorders

(Mary Ann Liebert, Inc./Genetic Engineering News) An important new article reviews recently discovered properties of adenosine A2A receptor-dopamine D2 receptor (A2AR-D2R) and adenosine A1 receptor-dopamine D1 receptor (A1R-D1R) heteromers -- both of which are main targets for caffeine -- and discusses the therapeutic implications of these findings.

Source: EurekAlert! - Medicine and Health - January 7, 2019 Category: International Medicine & Public Health Source Type: news